Osaic Holdings’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
DCM
ES
Osaic Holdings's IMNM Position: Q2 2026 in Review
Osaic Holdings increased its Immunome (IMNM) stake by 73% in Q2 2026, buying an estimated $26.4K and bringing the position to 2,929 shares worth $62.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5323.
Osaic Holdings first reported a position in IMNM in Q4 2020 and has held it in 16 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.
- Osaic Holdings held 2,929 shares of Immunome worth $62.1K as of Q2 2026.
- Osaic Holdings bought 1,232 Immunome shares in Q2 2026, an estimated $26.4K.
- Immunome made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5323 holding.
- Osaic Holdings first reported a position in Immunome in Q4 2020 and has held it in 16 quarters since.
- 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.